Danaher Issues Euro Notes to Finance Masimo Acquisition

Danaher ( (DHR) ) has shared an update.

On April 29, 2026, Danaher issued €3 billion in euro-denominated senior notes across four tranches, including floating-rate notes due 2028 and fixed-rate notes maturing between 2030 and 2038, as general unsecured senior indebtedness under its long-standing indenture structure. The securities include standard covenants, change-of-control protections, optional redemption features and a special mandatory redemption requirement if the planned acquisition of Masimo Corporation does not close by mid-November 2026 or the merger agreement is terminated.

The notes were sold via an underwritten offering led by major global banks, providing Danaher with net proceeds of about €2.98 billion to fund a portion of the Masimo acquisition consideration and related costs, with any remainder available for general corporate purposes including debt refinancing and capital needs. The financing underscores Danaher’s commitment to the Masimo deal while giving bondholders structural safeguards tied to completion of the transaction and preserving balance-sheet flexibility for future strategic and operational priorities.

The most recent analyst rating on (DHR) stock is a Buy with a $184.04 price target. To see the full list of analyst forecasts on Danaher stock, see the DHR Stock Forecast page.

Spark’s Take on DHR Stock

According to Spark, TipRanks’ AI Analyst, DHR is a Neutral.

The score is driven primarily by strong underlying financial quality (robust free cash flow, solid margins, manageable leverage) and a generally positive earnings-call outlook (raised EPS, strong Q1 execution, bioprocessing momentum). These positives are tempered by a premium valuation (high P/E and low yield) and only neutral-to-weak technical signals (below key longer-term moving averages and negative MACD).

To see Spark’s full report on DHR stock, click here.

More about Danaher

Danaher Corporation is a global science and technology conglomerate focused on life sciences, diagnostics and environmental and applied solutions, providing instruments, consumables and services to healthcare, laboratory and industrial customers. The company frequently uses the capital markets to fund strategic acquisitions and maintain its competitive position in these high-growth sectors.

Average Trading Volume: 4,361,122

Technical Sentiment Signal: Sell

Current Market Cap: $127.8B

For a thorough assessment of DHR stock, go to TipRanks’ Stock Analysis page.